Insurance companies systematically stopped covering safety measures like genetic testing, toxicology screens, and non-addictive topical creams, which could have prevented many opioid-related deaths.

The healthcare system is not just broken; it's designed to make more money when people are sick with chronic diseases, creating a perverse incentive for all players.

Insurance companies are disincentivized from investing in preventative care because patients often switch employers and become another insurer's problem before a chronic disease fully develops.

Pharmacy Benefit Managers (PBMs), owned by insurance companies, negotiate higher drug prices to receive larger kickbacks, called rebates, from pharmaceutical companies.

The FDA is cracking down on affordable compounded peptides like BPC-157 just as large pharmaceutical companies are attempting to patent and monetize them for massive profits.

A major conflict of interest exists as 10 out of the last 11 heads of the FDA went on to work for the pharmaceutical industry after leaving their government positions.

The American healthcare market is not truly free because corporate interests hide information and limit choices, preventing people from making educated decisions about their health.

Hospitals have no financial incentive to use a longer-lasting, innovative joint replacement because they make more money from repeat surgeries, which are paid for by insurance.

Insurance companies strategically deny claims knowing that their algorithms predict less than 10% of people will actually go through the effort to dispute the denial.